DexCom has been a great trade. While the S&P 500 was flat, the stock price has climbed by 8% to $74.17 per share. This run-up ...

upgrading the stock from Neutral to Buy and increasing the price target to $115 from the previous $85. Kirby highlighted DexCom's promising position in the continuous glucose monitoring (CGM ...

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...

Insulet (Nasdaq:PODD) announced today that it made its Omnipod 5 automated insulin delivery system available in several new ...

DexCom's growth is slowing ... there is something else going on if we zoom out a little bit and look at the CGM industry as a whole. DXCM has two competitors in the CGM industry: one is Abbott ...

situated within the strike price corridor from $70.0 to $125.0, throughout the last 30 days. Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients.

Bernstein increased their price objective on DexCom from $ ... Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring ...

Citigroup’s price target would indicate a potential ... Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system ...

CGM systems serve as an alternative to the ... an analyst from Morgan Stanley continues to hold a Equal-Weight rating for DexCom, targeting a price of $82. * Consistent in their evaluation ...